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Copyright © 2010 JCBN Summary Polaprezinc (PZ), a chelate compound consisting of zinc and L-carnosine (Car), is
an anti-ulcer drug developed in Japan. In the present study, we investigated whether PZ sup-
presses mortality, pulmonary inflammation, and plasma nitric oxide (NO) and tumor necrosis
factor (TNF)-α levels in endotoxin shock mice after peritoneal injection of lipopolysaccharide
(LPS), and how PZ protects against LPS-induced endotoxin shock. PZ pretreatment inhibited
the decrease in the survival rate of mice after LPS injection. PZ inhibited the increases in
plasma NO as well as TNF-α after LPS. Compatibly, PZ suppressed LPS-induced inducible
NO synthase mRNA transcription in the mouse lungs. PZ also improved LPS-induced lung
injury. However, PZ did not enhance the induction of heat shock protein (HSP) 70 in the
mouse lungs after LPS. Pretreatment of RAW264 cells with PZ suppressed the production of
NO and TNF-α after LPS addition. This inhibition likely resulted from the inhibitory effect of
PZ on LPS-mediated nuclear factor-κB (NF-κB) activation. Zinc sulfate, but not Car, sup-
pressed NO production after LPS. These results indicate that PZ, in particular its zinc sub-
component, inhibits LPS-induced endotoxin shock via the inhibition of NF-κB activation and
subsequent induction of proinflammatory products such as NO and TNF-α, but not HSP
induction.
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Introduction
Lipopolysaccharide (LPS), a major component of the outer
membrane of Gram-negative bacteria is a substance respon-
sible for endotoxin shock as well as a potent activator of
macrophages [1]. LPS is well known to induce production of
proinflammatory mediators such as nitric oxide (NO) and
cytokines including tumor necrosis factor-α (TNF-α),
leading to death from endotoxin shock in animal models [2,
3]. Moreover, in vitro studies have demonstrated that LPS
enhances cytokine and/or NO production in macrophages
[4], microglial cells [5] and endothelial cells [6]. LPS is
recognized by Toll-like receptor (TLR) 4 on the surface of
the host cells and its signal is transduced, resulting in the
activation of NF-κB [7], which is known to regulate tran-Polaprezinc Prevents Endotoxin Shock
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scriptions of many inflammation-related proteins including
cytokines [8].
Polaprezinc [N-(3-aminopropionyl)-L-histidinato zinc]
(PZ), a chelating compound of zinc and L-carnosine (Car),
is commonly used in the clinical field as a drug for gastric
ulcers in Japan [9]. Previously, both in vitro and in vivo
studies revealed that PZ prevented gastric mucosal injuries
by a variety of stimuli [10–13]. This mucosal protection
by PZ was attributed to its antioxidant activity [10,  11],
membrane-stabilizing action [12] and stimulation of mucus
production [13]. Recent in vitro studies have indicated the
importance of anti-apoptotic action of PZ in its protection
against gastrointestinal cell injuries [14, 15]. Furthermore, it
has been reported that PZ protects against the damages of
gastric and colonic mucosa by its potent heat shock protein
(HSP)-inducing activity [16–18]. Our recent study demon-
strated that PZ protected mouse primary cultured hepato-
cytes against acetaminophen insult due to HSP70 induction
and inhibition of lipid peroxidation [19]. It is known that
the overexpression of HSP70 inhibits the production of
cytokines and/or NO in macrophages activated by LPS
challenge [20]. Recently, we have found that oral admin-
istration of geranylgeranylacetone, a potent HSP inducer to
rats before LPS injection induces HSP70 in several organs,
inhibits production of proinflammatory cytokines and NO,
and prevents organ damages, resulting in improvement of
survival rates [21].
In the present study, we investigated whether PZ inhibited
LPS-induced endotoxin shock in mice as well as LPS-
mediated macrophage activation, whether the inhibition by
PZ was related to HSP induction, and how PZ protected
against LPS-mediated endotoxin shock.
Materials and Methods
Materials
PZ was kindly provided by Zeria Pharmaceutical Co.,
Ltd. (Tokyo, Japan). Zinc sulfate and Car were purchased
from Sigma-Aldrich (St. Louis, MO). Salmonella enterica
LPS serotype enteritidis was purchased from Sigma Chemical
Co. (St. Louis, MO). Fetal calf serum (FCS) was purchased
from PAA Laboratories GmbH (Linz, Austria). Rabbit anti-
HSP70 polyclonal antibody was purchased from Medical &
Biological Laboratories Co., Ltd. (Nagoya, Japan). Rabbit
anti-NF-κB p65 (H-286) polyclonal antibody was purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Dulbecco’s modified eagle medium (DMEM) was obtained
from Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan). All
the other chemicals used were of analytical grade.
Animals
Male ddY mice (5 weeks old) were purchased from Japan
SLC (Shizuoka, Japan) and housed 5–6 per cage in plastic
cages. The animals were maintained on a 12-h light/dark
cycle under controlled temperature (23 ± 3°C) and humidity
(55 ± 5%) for a week before use in experiments. They were
allowed free access to standard laboratory food and water.
All studies were approved by the Institutional Animal
Care and Use Committee at Tottori University Faculty of
Medicine, and were carried out in accordance with the
National Institutes of Health Guide for Care and Use of
Laboratory Animals.
Treatments of mice with PZ and LPS
LPS (40 mg/kg body weight) or vehicle (10% dimethyl
sulfoxide [DMSO] in phosphate-buffered saline [PBS]) was
administered intraperitoneally. The dose volume of LPS was
6 ml/kg. PZ was suspended in 0.5% carboxymethyl cellulose
sodium salt solution and given orally at a dose of 100 mg/kg
at 2 h before LPS administration. The dose volume of PZ
solution was 5 ml/kg. Mice were monitored for survival
over 96 h after LPS administration. Mice were anesthetized
with diethyl ether and blood samples were taken from the
right ventricle using a heparinized syringe with a needle 6,
12, 18, and 24 h after LPS administration. After the collec-
tion of blood, lungs were perfused with PBS, removed from
mice, frozen immediately, and stored in liquid nitrogen until
assayed.
Measurement of serum zinc concentration
Serum zinc concentrations were determined by atomic
absorption spectrophotometry (Fukuyama Medical Labora-
tory Co., Ltd., Hiroshima, Japan). Serum zinc concentration
was measured at 1, 2, 4 or 8 h after oral administration of
PZ (10, 50 or 100 mg/kg body weight).
Cell culture and treatments
RAW 264 murine macrophage cell line was obtained
from Riken BRC Cell Bank (Tsukuba, Japan), and grown
in DMEM supplemented with 10% heat-inactivated FCS,
2 mM glutamine and antibiotics (100 units/ml penicillin,
100 μg/ml streptomycin) at 37°C in a humidified incubator
with 5% CO2. All the experiments were performed using
DMEM containing 10% FCS unless described specifically.
The cells were seeded in a 24-well plate at a cell density
of 5 × 105 cells/well and incubated for 2 h at 37°C in an
atmosphere of 5% CO2/95% air. After non-adherent cells
were removed by washing with culture medium, attached
cells were exposed to LPS (100 ng/ml or 1 μg/ml) for
periods of 24 h at 37°C under 5% CO2/95% air. LPS was
dissolved in 10% DMSO in PBS. PZ was dissolved in
40 mM HCl. Zinc sulfate and Car were dissolved in distilled
water. PZ, zinc sulfate or Car at concentrations of 50 or
100 μM was added into the medium 6 or 2 h before LPS
administration.S. Ohata et al.
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Determination of NO
Plasma NO2/NO3 level or the nitrite in the culture medium
was determined as an index of NO production spectro-
photometrically by means of commercially available kits
(Wako Pure Chemistry Industries, Osaka, Japan) [21, 22].
Determination of TNF-α
The TNF-α in plasma or the culture medium was
determined with an enzyme-linked immunosorbent assay
(ELISA) kit (BioSource International, Camarillo, CA)
according to the manufacturer’s instructions [21, 22].
Western blot analysis
Contents of HSP70 or nuclear NF-κB p65 were deter-
mined by western blotting as described previously [23, 24].
Nuclear extracts were prepared by using NE-PER® Nuclear
and Cytoplasmic Extraction Reagents (Pierce Biothecnology,
Rockford, IL) according to the manufacturer’s instructions.
Frozen lung tissues or nuclear extracts from RAW 264 cells
were homogenized and 40 μg of protein from each sample
was separated by SDS polyacrylamide gel electrophoresis
with 12.5% polyacrylamide gel. The gels were electro-
blotted onto polyvinylidene difluoride membranes. The
membranes were incubated with rabbit anti-HSP70 poly-
clonal antibody (1:10000) or rabbit anti-NF-κB p65 anti-
body (1:2000), washed and then incubated with horseradish-
peroxidase-conjugated goat anti-rabbit (Sigma Chemical
Co., St. Louis, MO) antibody. The immunoblot was revealed
with an ECLTM Western blotting analysis system (Amersham
Pharmacia Biotech, Buckinghamshire, England). Western
blots were quantified with Scion Image.
Real-time reverse transcriptase-polymerase chain reaction
(Real-tme PCR)
Total RNA was extracted from lung using the RNeasy®
Mini Kit (Qiagen Japan, Tokyo, Japan). Both reverse tran-
scription and PCR were carried out in a single tube using a
QuantiFast SYBR® Green RT-PCR Kit (Qiagen Japan).
We used QuantiTect® Primer Assays (Quiagen Japan) for
real-time PCR primers. The accession numbers of the
primers are as follows: Nitric oxide synthase 2 (iNOS),
Mm_Nos2_1_SG, QT00100275; Metallothionein 1,
Mm_Mt1_1_SG, QT00265902; Metallothionein 2,
Mm_Mt2_1_SG, QT00264278. A β-2 microglobulin primer
(Mm_B2m_2_SG, QT01149547, Qiagen Japan) was used
as an endogenous control. The relative amounts of all
mRNAs were measured using a 7900HT Fast Real-Time
PCR System (Applied Biosystems Japan, Tokyo, Japan).
Lung histopathology
For lung histopathological examination, the lungs were
distended by infusion of 10% formalin into the trachea at a
pressure of 15 cm H2O for 2 h, and fixed in 10% formalin
for 24 h. Formalin-fixed lungs were embedded in paraffin,
sectioned and stained with hematoxylin and eosin (H-E). To
estimate the extent of damage, the specimen was observed
under a light microscope.
Protein assay
Protein contents were determined by the method of
Bradford [25] with bovine serum albumin as a standard.
Statistical evaluations
Data are expressed as mean ± standard error (SE).
Changes in variables for different assays were analyzed by
Student’s t test or one-way ANOVA. Survival studies were
analyzed by Chi-square test. Differences were considered to
be significant at p<0.05.
Results
Changes in serum zinc concentration after PZ administra-
tion
When healthy adult males received 300 mg of PZ in a
fasting state, plasma zinc concentration increased linearly,
reached a maximum (approximately 300 μg/dl) at 2 h after
PZ intake, and thereafter reduced and became a normal level
at 8 h after PZ (according to company data of Zeria Pharma-
ceutical). To determine optimal administration time and
dose of PZ for mice, serum zinc concentration was measured
at 1, 2, 4 or 8 h after oral treatment of mice with PZ (10, 50
or 100 mg/kg body weight) (Fig. 1). Serum zinc level
increased in a dose-dependent manner and the level reached
a maximum 1 h after administration of PZ to mice and
subsequently decreased in a time-dependent manner.
Fig. 1. Changes in serum zinc levels in mice after PZ intake. PZ
(10, 50 or 100 mg/kg, p.o.) was given to mice, and blood
samples were taken 1, 2, 4, or 8 h after PZ administra-
tion. Serum zinc concentration was measured as described
in Materials and Methods. Data points represent the
means ± SE (n =6 ) .Polaprezinc Prevents Endotoxin Shock
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Effect of PZ pretreatment on survival rate in mice after LPS
administration
The survival rate decreased to 20% at 96 h after LPS
injection. Oral administrations of PZ (100 mg/kg) at 2 h
and 1 h before LPS significantly increased survival rates to
80% and 55%, respectively (Fig. 2). Although serum zinc
level in mice treated with PZ at 1 h before LPS was higher
than that in 2-h treatment of mice with PZ (see Fig. 1),
treatment with PZ at 2 h before LPS improved the survival
rate better than 1-h treatment with PZ.
Given these results, mice were administered 100 mg/kg of
PZ at 2 h before LPS in the following experiments.
Effect of PZ pretreatment on plasma NO levels in mice after
LPS administration
Plasma NO increased with time up to 24 h after LPS
administration. Pretreatment of mice with PZ inhibited LPS-
mediated NO production (Fig. 3A).
Effect of PZ pretreatment on plasma TNF-α levels in mice
after LPS administration
Plasma TNF-α level also increased time-dependently,
reached a maximum at 18 h and decreased at 24 h after LPS
injection. Pretreatment of mice with PZ inhibited LPS-
mediated TNF-α production (Fig. 3B).
Effect of PZ pretreatment on lung histology in mice after
LPS administration
LPS induced histological changes in the mouse lung such
as inflammatory cell infiltration, peri-vascular edema and
marked alveolar hemorrhage in comparison with control or
PZ alone-treated lungs. PZ pretreatment improved such
pulmonary damages remarkably (Fig. 4).
Effect of PZ pretreatment on expression of HSP70 in mouse
lung after LPS
Although PZ is known to be a potent HSP inducer in
stomach and colon [16–18], PZ did not enhance the induc-
tion of pulmonary HSP70 after LPS administration (Fig. 5).
Effect of PZ pretreatment on iNOS gene expression in mouse
lung after LPS
We determined the effect of PZ on expression of iNOS
mRNA 6 h after LPS injection (Fig. 6). LPS treatment
Fig. 2. Time course of survival rate of mice treated with PZ
followed by LPS. PZ (100 mg/kg) was given to mice 1
or 2 h before LPS (40 mg/kg, i.p.) administration. Mice
were monitored for survival over 96 h after LPS
administration. PZ-2 h and PZ-1 h received PZ at 2 h
and 1 h before LPS administration, respectively. #p<0.01
vs LPS alone at 96 h after LPS. $p<0.01 vs PZ-1 h at
96 h after LPS.
Fig. 3. Inhibition by PZ of NO (A) and TNF-α (B) in plasma in mice injected with LPS. PZ (100 mg/kg) was given to mice 2 h before
LPS (40 mg/kg, i.p.) administration. Blood samples were collected 6, 12, 18, 24 h after administration of LPS. Plasma NO and
TNF-α concentrations were measured as described in Materials and Methods. Data points represent the means ± SE (n =5 ) .
*p<0.01 vs LPS alone.S. Ohata et al.
J. Clin. Biochem. Nutr.
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increased iNOS mRNA level in the lung approximately 20-
fold of normal level. PZ administration 2 h before LPS
significantly reduced the increase in iNOS mRNA gene
expression by around 50%. In contrast, there was no
difference of metallothionein-I (MT-I) and metallothionein-
II (MT-II) mRNA levels between treatment with LPS alone
and pretreatment with PZ at 2 h before LPS although MT-I
and MT-II gene expressions increased remarkably in both
Fig. 4. Effect of PZ on lung injury in mice 24 h after LPS administration. Mice were treated with PZ (100 mg/kg, p.o.) 2 h before LPS
(40 mg/kg, i.p.) administration. Lung histopathological analysis was performed as described in Materials and Methods. Cont.
(upper left): lung from control mouse; PZ (upper right): lung from mouse treated with PZ (100 mg/kg) alone; LPS (lower left):
lung from mouse treated with LPS alone; PZ + LPS (lower right): lung from mouse treated with PZ at 2 h before LPS (H-E,
magnification ×20).
Fig. 5. Effect of PZ pretreatment on HSP70 induction in the
mouse lung 24 h after LPS administration. PZ (100 mg/
kg) was given to mice 2 h before LPS (40 mg/kg, i.p.)
administration. HSP70 level was analyzed by western
blotting. Representative western blots of HSP70 from 3
separate experiments are shown.
Fig. 6. Effect of PZ on the expression of iNOS mRNA in the
mouse lung 6 h after LPS. PZ (100 mg/kg) was given to
mice 2 h before LPS (40 mg/kg, i.p.) administration. The
level of iNOS mRNA in the mouse lung was measured
as described in Materials and Methods. Data points
represent the means ± SE (n = 5). *p<0.05 vs LPS alone.Polaprezinc Prevents Endotoxin Shock
Vol. 46, No. 3, 2010
239
groups (data not shown).
Effect of PZ on LPS-mediated production of NO and TNF-α
in RAW 264 cells
Treatment of RAW 264 cells with PZ (100 μM) at 6 h
before LPS addition significantly suppressed NO production
at 24 h as well as TNF-α production at 4 h after LPS
(Fig. 7A and B).
Effect of PZ on LPS-mediated NF-κB activation in RAW 264
cells
LPS is known to induce the expressions of iNOS and
inflammatory cytokines such as TNF-α, IL-1β, IL-6 and
IFN-γ [8], via activation of NF-κB. We next examined by
western blot analysis whether PZ suppressed LPS-induced
nuclear translocation of NF-κB in RAW 264 cells. LPS
(100 ng/ml) caused the translocation of NF-κB p65 into the
Fig. 7. Inhibitory effect of PZ on LPS-mediated production of NO (A) and TNF-α (B) in RAW 264 cells. Cells were incubated in the
presence of LPS (100 ng/ml) for 24 h (A) or 4 h (B) at 37°C under a 5% CO2 and 95% air atmosphere. PZ (100 μM) was added
6 h before the addition of LPS. The levels of NO and TNF-α were measured as described in Materials and Methods. Data points
represent the means ± SE (n =3 ) .  * p<0.05 vs LPS alone-treated cells.
Fig. 8. Inhibitory effect of PZ on LPS-mediated NF-κB activation in RAW 264 cells. Cells were incubated in the presence of LPS
(100 ng/ml) for 24 h at 37°C under a 5% CO2 and 95% air atmosphere. PZ (100 μM) was added 6 h before the addition of LPS.
Nuclear translocation of NF-κB p65 as an index of NF-κB activation was analyzed by western blotting, quantified densito-
metrically as described in Materials and Methods, and expressed as relative density to control cells. Data points represent the
means ± SE (n =3 ) .  * p<0.05 vs LPS alone-treated cells at 24 h after LPS.S. Ohata et al.
J. Clin. Biochem. Nutr.
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nucleus in a time-dependent manner, and PZ pretreatment
6 h before LPS significantly inhibited the nuclear transloca-
tion at 24 h after LPS addition (Fig. 8).
Effect of zinc sulfate or Car on LPS-mediated NO produc-
tion in RAW 264 cells
Since PZ consists of zinc and Car, we investigated the
effect of zinc or Car alone on LPS-induced NO production
in RAW 264 cells. Treatment of the cells with zinc sulfate
also inhibited NO production at 24 h after LPS addition in a
dose-dependent manner. In contrast, Car failed to inhibit NO
production (Fig. 9).
Discussion
In the present study, PZ pretreatment improved the survival
rate of mice treated with LPS dramatically. Multiple organ
failure (MOF) is considered to be a direct cause of death
by sepsis and/or endotoxemia [26]. Since acute lung injury
(ALI), a significant cause of morbidity and mortality, often
occurred in the context of MOF [27], we carried out lung
histological examinations. These experiments illustrated
that LPS caused severe lung damage compatible with ALI
and PZ suppressed the damage remarkably (Fig. 4). We
also examined whether LPS caused hepatic and renal
injuries in mice. LPS increased plasma alanine amino-
transferase (ALT) as an index of liver injury to just only 5-
fold of normal level at 18 h after the injection (data not
shown), although the ALT level was increased to several
hundreds fold of normal level in the cases of lethal hepatic
injuries such as acetaminophen-induced hepatotoxicity [28,
29]. In contrast, LPS did not increase plasma creatinine
levels in our experimental model (data not shown).
NF-κB is activated in response to LPS and the expression
of iNOS and other proinflammatory gene products is
enhanced, leading to overproduction of NO and proinflam-
matory cytokines including TNF-α [ 8]. NO reacts with
superoxide radical to produce peroxynitrite (ONOO−) at a
rate near the diffusion-controlled limit (7 × 109 M−1s−1) [30].
Therefore, these two reactive species must be generated in
the same cells as shown in macrophages and neutrophils or
exist near to interact each other. Production of ONOO−, a
highly reactive nitrogen species, causes protein nitration
followed by cell death [30]. TNF-α is one of the early
proinflammatory cytokines secreted during LPS-induced
endotoxin shock and is primarily secreted by macrophages
and neutrophils [31]. TNF-α has been reported to induce
cytokine-induced neutrophil chemoattractant-1 in rat gastric
mucosal cells in a NF-κB-dependent manner [32]. PZ
pretreatment inhibited the production of NO and TNF-α
induced by administration of LPS to mice (Fig. 3A and B).
PZ-mediated inhibition of LPS-induced NO production
likely resulted from the inhibition of iNOS mRNA transcrip-
tion. As mentioned above, NF-κB is involved in the induc-
tion of iNOS. It has been reported that PZ inhibits NF-κB
activation in gastric epithelial cells [33] and rat colonic
mucosa [34]. Therefore, we determined the effect of PZ on
NF-κB activation in RAW 264 macrophage cells after LPS
challenge. PZ significantly inhibited LPS-stimulated activa-
tion of NF-κB, resulting in the inhibition of NO and TNF-α
production in RAW 264 cells (Figs. 7 and 8). Zinc, one of
PZ subcomponents, has a dual effect on the secretion of
proinflammatory cytokines, i.e., potentiation and suppres-
sion [35]. This is explained by a concentration-dependent
process in which low zinc doses potentiate the LPS effect,
whereas high concentrations inhibit monokine secretion
[35]. Zinc is well known to inhibit NF-κB activation by a
variety of stimuli [35–37]. In contrast, it has been reported
that zinc plays an important role in activation of NF-κB in
HUT-78, a Th0 human malignant lymphoblastoid cell line
[38]. Since zinc, but not Car, suppressed LPS-induced NO
production in RAW 264 cells (Fig. 9), the inhibition of
NF-κB activation by PZ is likely ascribed to zinc sub-
component. There are at least two potential mechanisms
underlying the inhibition by zinc against NF-κB activation
as follows: (1) Zinc induces protein kinase A activation
and subsequently inhibits nuclear translocation of NF-κB
after LPS challenge [35]; (2) Zinc inhibits NF-κB-induced
expression of inflammatory cytokines through the induction
of A20, a zinc-finger transactivating factor [39].
It has been shown that the production of proinflammatory
cytokines is inhibited by the HSP70 induction [2,  40].
Furthermore, overexpressed HSP70 potentiates resistance to
Fig. 9. Effect of PZ subcomponents on LPS-mediated NO pro-
duction in RAW 264 cells. Cells were incubated in the
presence of LPS (100 ng/ml) for 24 h at 37°C under a
5% CO2 and 95% air atmosphere. Zinc sulfate (Zn) or
Car was added to the culture at the concentration of 50 or
100 μM 2 h before starting the 24-incubation with LPS.
NO level was measured as described in Materials and
Methods. Data points represent the means ± SE (n =3 ) .
*p<0.05 vs LPS alone-treated cells.Polaprezinc Prevents Endotoxin Shock
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apoptosis and oxidative stress [41]. Recently, PZ is reported
to induce HSP70 (HSP72) in rat gastric mucosa, mouse
colonic mucosa, human colon cells and mouse hepatocytes,
and protect against injuries induced by a variety of stimuli
[16–19, 42]. Therefore, we examined whether HSP70 induc-
tion was involved in the protection by PZ of LPS-induced
lung injury. However, PZ did not enhance LPS-mediated
HSP70 protein expression in the mouse lung. Van Molle
et al. revealed that zinc induced HSP70 expression in mice,
particularly in the liver and small intestine, but HSP70
expression in the lung remained rather low [43]. They
explained that this is a more specific expression pattern
compared with whole-body heat shock, which also induced
HSP70 in other organs such as colon and lung. Several
investigators have reported that NF-κB transcription could
be inhibited by induction of HSP72 through stabilization of
IκB and prevention of its phosphorylation [44, 45]. Recent
study demonstrated that expression of HSP72 was signifi-
cantly up-regulated and NF-κB activation was markedly
inhibited in the colonic mucosa in rats pretreated with PZ
[34]. Therefore, it was considered that the induction of
HSP70 was not involved in mechanisms of NF-κB suppres-
sion by PZ in our experiments. Since previous studies
reported on tissues and/or cells of gastrointestinal tract
and liver, this discrepancy might be due to the difference
of organ. The further studies should be required for fully
understanding the mechanisms.
The induction of MT is known as one of important
biological activities of zinc, a PZ subcomponent. MT, an
important protein induced by metals, is shown to play a
protective role in a lot of experimental models [46]. MTs
are a superfamily of small proteins that are present in
virtually every living organism. In mice, only four func-
tional murine MT genes are known (MT-I, MT-II, MT-III,
and MT-IV), and highly inducible MT-I and MT-II isoforms
are coordinately regulated [47]. Therefore, we examined the
effect of PZ pretreatment on the increase in MT-I and MT-II
mRNA levels in the mouse lung after LPS administration.
However, it did not affect the MT gene expressions after
LPS (data not shown). The study using MT-I/II knock out
mice has demonstrated that endogenous MT protects against
ALI induced by LPS possibly via a protective effect on the
vascular integrity, but not through inhibition of the NF-κB
pathway and subsequent proinflammatory cytokine expres-
sion [48]. Given that PZ inhibited NF-κB activation as well
as increases in NO and TNF-α levels after LPS challenge,
it is suggested that MT induction is not involved in the
protective effect of PZ on LPS-induced endotoxin shock in
our experimental model.
In conclusion, the present study has shown that PZ
protects against LPS-induced endotoxin shock via inhibition
of NF-κB activation and subsequent induction of pro-
inflammatory products including NO and TNF-α.
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